Logo

Allero Therapeutics BV

EIC Accelerator Winner From 2021

Novel First-in-Class Specific Oromucosal Immunotherapy (SOMIT) to treat Celiac Disease (CD)

Visit Website
Netherlands

Articles

EIC Accelerator Funding Boosts Allero Therapeutics' Innovative Immunotherapy Development

NetherlandsEIC Accelerator2021
Read Article
Back to All Companies

EIC Accelerator Deadline

00
Days
00
Hours
00
Minutes
00
Seconds

How Can We Help You Succeed?

AI Writer

Budget-friendly AI tools, templates and instructions

Advisory Service

Personalized support for teams with in-house writers

Full Writing

Full Writing of all Proposal Sections by Stephan Segler, PhD